QCM
ZBH icon

Qsemble Capital Management’s Zimmer Biomet ZBH Stock Holding History

Qsemble Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,059
Closed -$616K – 550
2023
Q4 		$616K Sell
5,059
-35,541
-88% -$3.97M 0.15% 212
2023
Q3 		$4.56M Buy
40,600
+38,000
+1,462% +$4.83M 0.85% 22
2023
Q2 		$379K Buy
+2,600
New +$353K 0.27% 134

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qsemble Capital Management's ZBH Position: Q1 2024 in Review

Qsemble Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 5,059 shares — an estimated $616K sold.

Qsemble Capital Management first reported a position in ZBH in Q2 2023 and held it in 3 quarters. The position peaked at $4.56M in Q3 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Qsemble Capital Management reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Qsemble Capital Management sold 5,059 Zimmer Biomet shares in Q1 2024, an estimated $616K.
  • Qsemble Capital Management first reported a position in Zimmer Biomet in Q2 2023 and held it in 3 quarters.
  • Qsemble Capital Management's Zimmer Biomet position peaked at $4.56M in Q3 2023.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Qsemble Capital Management's 13F filing for Q1 2024, filed 7 May 2024.